Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROXICODONE vs RUCAPARIB CAMSYLATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROXICODONE vs RUCAPARIB CAMSYLATE: Safety Overview

Metric ROXICODONE RUCAPARIB CAMSYLATE
Total FAERS Reports 106 8,240
Deaths Reported 90 448
Death Rate 84.9% 5.4%
Hospitalizations 6 1,148
Average Patient Age 45.3 yrs 65.1 yrs
% Female Patients N/A 95.2%
FDA Approval Date N/A Dec 19, 2016
Manufacturer N/A pharmaand GmbH
Route N/A ORAL
Marketing Status N/A Prescription